• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. TVT EXACT RETROPUBIC SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. TVT EXACT RETROPUBIC SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Catalog Number TVTRL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Micturition Urgency (1871); Incontinence (1928); Sepsis (2067); Urinary Tract Infection (2120)
Event Date 09/19/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Please provide the patient's demographic information including weight, bmi at the time of index procedure name of index surgical procedure? the diagnosis and indication for the index surgical procedure? were any concomitant procedures performed? other relevant patient history/concomitant medications? were there any pre-existing signs/symptoms of active infection prior to this surgical procedure? did the patient receive any prophylactic antibiotics pre-, intra- or post-operation? were cultures performed? if so, please provide the results.Please describe any medical intervention performed including medication name and results.What is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status? surgeon¿s name? to date it has been reported that the device will not be returned.If the device or further details are received at a later date a supplemental medwatch will be sent.H6 component code: g07002 ¿ device not returned.A review of the batch manufacturing records was conducted, and no related non-conformances were identified.
 
Event Description
It was reported that a patient underwent a sling procedure on (b)(6) 2022 and mesh was implanted.On (b)(6) 2022, mild urgency incontinence was noted.This event was reported as possibly related to the study device and study procedure.The patient stated she is still experiencing some urgency incontinence but it has been improving every day since it was reported.Per her conversation with surgeon, she believes and is confident this is just part of recovery and should be completely resolved in a few more weeks.On (b)(6) 2023, severe urosepsis was noted and the patient was hospitalized on (b)(6) 2023.The patient received unspecified drug therapy and the event was recovered/resolved without sequelae as of (b)(6) 2024.The urosepsis was reported as unlikely related to the study device or study procedure.Additional information has been requested.
 
Manufacturer Narrative
(b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested and the following response was received: please provide the patient's demographic information including weight, bmi at the time of index procedure female, 101.7kg, 34.10 name of index surgical procedure? sling operation for stress incontinence the diagnosis and indication for the index surgical procedure? stress incontinence were any concomitant procedures performed? yes- see edc other relevant patient history/concomitant medications? n/a were there any pre-existing signs/symptoms of active infection prior to this surgical procedure? no.Did the patient receive any prophylactic antibiotics pre-, intra- or post-operation?no were cultures performed? if so, please provide the results.No please describe any medical intervention performed including medication name and results.Went to ed ¿ got antibiotics cefuroxime and doxycycline - resolved what is the physician¿s opinion as to the etiology of or contributing factors to this event?: urinary tract infection.What is the patient's current status?: recovered.
 
Manufacturer Narrative
(b)(4) this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Updated information received: adverse event term: urgency incontinence did this event result in the subject's discontinuation of the study?if yes, complete the study discontinuation form.: blank no if the event is marked as being related to the procedure, indicate which procedure the event is related to: blank index.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TVT EXACT RETROPUBIC SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON SARL-NEUCHATEL
puits-godet 20
neuchatel 2000
SZ   2000
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key18739481
MDR Text Key335761098
Report Number2210968-2024-01552
Device Sequence Number1
Product Code OTN
UDI-Device Identifier10705031062375
UDI-Public10705031062375
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date02/28/2023
Device Catalogue NumberTVTRL
Device Lot Number3941149
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/09/2024
Initial Date FDA Received02/20/2024
Supplement Dates Manufacturer Received03/04/2024
Not provided
Supplement Dates FDA Received03/12/2024
05/30/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/03/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient SexFemale
Patient Weight101 KG
-
-